Capstone Holding Corp. — Director's Dealing 2015

Apr 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2015-04-10

Reporting Person: STEER RANDOLPH C (Consultant)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-10	Stock Option (Right to Buy)	$0.17	A	40000	Acquired	2025-04-10	Common Stock (40000)	Direct

Footnotes

F1: 50% to vest 4/10/15 and 50% to vest monthly by 4/10/16